INTRODUCTION AND AIMS: For women who carry BRCA mutations, risk-reducing surgeries are an option to decrease breast and ovarian cancer risk. This study aims to determine the uptake, time course, and predictors of risk-reducing mastectomy (RRM) and risk-reducing salpingo-oophorectomy (RRSO) in BRCA carriers. RESULTS: In 272 female carriers, followed for a median of 3.7 years, 23% of those eligible chose RRM, and 51% percent chose RRSO. Among BRCA carriers who chose these procedures, median time to both RRM and RRSO was approximately 4 months after learning of BRCA-positive results. Predictors of RRM were as follows: age below 60 years (hazard ratio 1.8, p=0.04), prior breast cancer (hazard ratio 2.4, p=0.0004), and RRSO (hazard ratio 7.2, p<0.0001). Predictors of RRSO were as follows: age below 60 years (hazard ratio 3.6, p=0.006), prior breast cancer (hazard ratio 1.8, p=0.002), and RRM (hazard ratio 5.4, p<0.0001). CONCLUSIONS: Many women who undergo BRCA testing use these results to make clinical decisions; those who choose risk-reducing surgeries typically do so within months of receiving BRCA-positive results. Predictors of risk-reducing surgery uptake include the following: age below 60 years, prior breast cancer, and utilization of another risk-reducing surgery. Future research directions include examining other preventive and screening options in BRCA carriers as well as studying motivations for choosing or declining risk-reducing surgeries.
INTRODUCTION AND AIMS: For women who carry BRCA mutations, risk-reducing surgeries are an option to decrease breast and ovarian cancer risk. This study aims to determine the uptake, time course, and predictors of risk-reducing mastectomy (RRM) and risk-reducing salpingo-oophorectomy (RRSO) in BRCA carriers. RESULTS: In 272 female carriers, followed for a median of 3.7 years, 23% of those eligible chose RRM, and 51% percent chose RRSO. Among BRCA carriers who chose these procedures, median time to both RRM and RRSO was approximately 4 months after learning of BRCA-positive results. Predictors of RRM were as follows: age below 60 years (hazard ratio 1.8, p=0.04), prior breast cancer (hazard ratio 2.4, p=0.0004), and RRSO (hazard ratio 7.2, p<0.0001). Predictors of RRSO were as follows: age below 60 years (hazard ratio 3.6, p=0.006), prior breast cancer (hazard ratio 1.8, p=0.002), and RRM (hazard ratio 5.4, p<0.0001). CONCLUSIONS: Many women who undergo BRCA testing use these results to make clinical decisions; those who choose risk-reducing surgeries typically do so within months of receiving BRCA-positive results. Predictors of risk-reducing surgery uptake include the following: age below 60 years, prior breast cancer, and utilization of another risk-reducing surgery. Future research directions include examining other preventive and screening options in BRCA carriers as well as studying motivations for choosing or declining risk-reducing surgeries.
Authors: Robin Lee; Mary Beattie; Beth Crawford; Julie Mak; Nicola Stewart; Miriam Komaromy; Laura Esserman; Lucille Shaw; Jane McLennan; Lori Strachowski; Judy Luce; John Ziegler Journal: Genet Test Date: 2005
Authors: E Levy-Lahad; R Catane; S Eisenberg; B Kaufman; G Hornreich; E Lishinsky; M Shohat; B L Weber; U Beller; A Lahad; D Halle Journal: Am J Hum Genet Date: 1997-05 Impact factor: 11.025
Authors: C Lerman; C Hughes; R T Croyle; D Main; C Durham; C Snyder; A Bonney; J F Lynch; S A Narod; H T Lynch Journal: Prev Med Date: 2000-07 Impact factor: 4.018
Authors: D Ford; D F Easton; M Stratton; S Narod; D Goldgar; P Devilee; D T Bishop; B Weber; G Lenoir; J Chang-Claude; H Sobol; M D Teare; J Struewing; A Arason; S Scherneck; J Peto; T R Rebbeck; P Tonin; S Neuhausen; R Barkardottir; J Eyfjord; H Lynch; B A Ponder; S A Gayther; M Zelada-Hedman Journal: Am J Hum Genet Date: 1998-03 Impact factor: 11.025
Authors: Noah D Kauff; Karen E Hurley; Martee L Hensley; Mark E Robson; Gali Lev; Deborah Goldfrank; Mercedes Castiel; Carol L Brown; Jamie S Ostroff; Lucy E Hann; Kenneth Offit; Richard R Barakat Journal: Cancer Date: 2005-07-15 Impact factor: 6.860
Authors: C Bethan Powell; Eric Kenley; Lee-May Chen; Beth Crawford; Jane McLennan; Charles Zaloudek; Miriam Komaromy; Mary Beattie; John Ziegler Journal: J Clin Oncol Date: 2005-01-01 Impact factor: 44.544
Authors: Y Miki; J Swensen; D Shattuck-Eidens; P A Futreal; K Harshman; S Tavtigian; Q Liu; C Cochran; L M Bennett; W Ding Journal: Science Date: 1994-10-07 Impact factor: 47.728
Authors: Deborah Cragun; Anne Weidner; Courtney Lewis; Devon Bonner; Jongphil Kim; Susan T Vadaparampil; Tuya Pal Journal: Cancer Date: 2017-02-09 Impact factor: 6.860
Authors: Xinglei Chai; Tara M Friebel; Christian F Singer; D Gareth Evans; Henry T Lynch; Claudine Isaacs; Judy E Garber; Susan L Neuhausen; Ellen Matloff; Rosalind Eeles; Nadine Tung; Jeffrey N Weitzel; Fergus J Couch; Peter J Hulick; Patricia A Ganz; Mary B Daly; Olufunmilayo I Olopade; Gail Tomlinson; Joanne L Blum; Susan M Domchek; Jinbo Chen; Timothy R Rebbeck Journal: Breast Cancer Res Treat Date: 2014-10-14 Impact factor: 4.872
Authors: Stephanie Kearton; Karen Wills; Michael Bunting; Penny Blomfield; Paul A James; Jo Burke Journal: Fam Cancer Date: 2018-07 Impact factor: 2.375
Authors: Karin M Landsbergen; Judith B Prins; Yvonne J L Kamm; Han G Brunner; Nicoline Hoogerbrugge Journal: Fam Cancer Date: 2010-06 Impact factor: 2.375
Authors: Gabriel N Mannis; Julia E Fehniger; Jennifer S Creasman; Vanessa L Jacoby; Mary S Beattie Journal: JAMA Intern Med Date: 2013-01-28 Impact factor: 21.873
Authors: Charles W Drescher; J David Beatty; Robert Resta; M Robyn Andersen; Kate Watabayashi; Jason Thorpe; Sarah Hawley; Hannah Purkey; Jessica Chubak; Nancy Hanson; Diana S M Buist; Nicole Urban Journal: Cancer Date: 2016-07-22 Impact factor: 6.860